The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances
Open accessAbstract
Pathogenic bacteria infection is a major public health problem due to the high morbidity and mortality rates, as well as the increased expenditure on patient management. Although there are several options for antimicrobial therapy, their efficacy is limited because of the occurrence of drug-resistant bacteria. Many conventional antibiotics have failed to show significant amelioration in overall survival of infectious patients. Nanomedicine for delivering antibiotics provides an opportunity to improve the efficiency of the antibacterial regimen. Nanosystems used for antibiotic delivery and targeting to infection sites render some benefits over conventional formulations, including increased solubility, enhanced stability, improved epithelium permeability and bioavailability, prolonged antibiotic half-life, tissue targeting, and minimal adverse effects. The nanocarriers' sophisticated material engineering tailors the controllable physicochemical properties of the nanoparticles for bacterial targeting through passive or active targeting. In this review, we highlight the recent progress on the development of antibacterial nanoparticles loaded with antibiotics. We systematically introduce the concepts and amelioration mechanisms of the nanomedical techniques for bacterial eradication. Passive targeting by modulating the nanoparticle structure and the physicochemical properties is an option for efficient drug delivery to the bacteria. In addition, active targeting, such as magnetic hyperthermia induced by iron oxide nanoparticles, is another efficient way to deliver the drugs to the targeted site. The nanoparticles are also designed to respond to the change in environment pH or enzymes to trigger the release of the antibiotics. This article offers an overview of the benefits of antibacterial nanosystems for treating infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Characterization of enhanced antibacterial effects of novel silver nanoparticles
Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P., & Dash, D. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/22/225103 · Cited by 1,523
RetractedTong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Review on Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism
Sirelkhatim, A., Mahmud, S., Seeni, A., Kaus, N. H. M., Ann, L. C., Bakhori, S. K. M., Hasan, H., & Mohamad, D. (2015) · Nano-Micro Letters · doi:10.1007/s40820-015-0040-x · Cited by 4,586
Pal, S., Tak, Y. K., & Song, J. M. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.02218-06 · Cited by 4,040
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
P25-Graphene Composite as a High Performance Photocatalyst
Zhang, H., Lv, X., Li, Y., Wang, Y., & Li, J. (2010) · ACS Nano · doi:10.1021/nn901221k · Cited by 3,184
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Metal nanoparticles: understanding the mechanisms behind antibacterial activity
Slavin, Y. N., Asnis, J., Häfeli, U. O., & Bach, H. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0308-z · Cited by 2,571
Physiological heterogeneity in biofilms
Stewart, P. S., & Franklin, M. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1838 · Cited by 2,327
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
Paczosa, M. K., & Mecsas, J. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00078-15 · Cited by 1,988
Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
Lok, C.-N., Ho, C.-M., Chen, R., He, Q.-Y., Yu, W.-Y., Sun, H., Tam, P. K.-H., Chiu, J.-F., & Che, C.-M. (2006) · Journal of Proteome Research · doi:10.1021/pr0504079 · Cited by 1,581
Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids)
Zhang, L., Jiang, Y., Ding, Y., Povey, M., & York, D. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-006-9150-1 · Cited by 1,490
Size Dependent and Reactive Oxygen Species Related Nanosilver Toxicity to Nitrifying Bacteria
Choi, O., & Hu, Z. (2008) · Environmental Science & Technology · doi:10.1021/es703238h · Cited by 1,391
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Graphene: Corrosion-Inhibiting Coating
Prasai, D., Tuberquia, J. C., Harl, R. R., Jennings, G. K., & Bolotin, K. I. (2012) · ACS Nano · doi:10.1021/nn203507y · Cited by 1,291
Yang, H., Liu, C., Yang, D., Zhang, H., & Xi, Z. (2009) · Journal of Applied Toxicology · doi:10.1002/jat.1385 · Cited by 1,087
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function
Huang, X., Teng, X., Chen, D., Tang, F., & He, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.060 · Cited by 1,002
Surface Charge-Dependent Toxicity of Silver Nanoparticles
El Badawy, A. M., Silva, R. G., Morris, B., Scheckel, K. G., Suidan, M. T., & Tolaymat, T. M. (2011) · Environmental Science & Technology · doi:10.1021/es1034188 · Cited by 922
Yamanaka, M., Hara, K., & Kudo, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.11.7589-7593.2005 · Cited by 905
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805 · cited 1×
“tuberculosis has led to the failure of first line therapy and prolonged treatment duration (Seung et al., 2015).”
BackgroundInvolvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa
Barraud, N., Hassett, D. J., Hwang, S.-H., Rice, S. A., Kjelleberg, S., & Webb, J. S. (2006) · Journal of Bacteriology · doi:10.1128/jb.00779-06 · Cited by 783
Anatase TiO2 Nanocomposites for Antimicrobial Coatings
Fu, G., Vary, P. S., & Lin, C.-T. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp0502196 · Cited by 764
Zinc oxide nanoparticles: Synthesis, antiseptic activity and toxicity mechanism
Król, A., Pomastowski, P., Rafińska, K., Railean-Plugaru, V., & Buszewski, B. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.07.033 · Cited by 731
Toxicity Mechanisms in Escherichia coli Vary for Silver Nanoparticles and Differ from Ionic Silver
Ivask, A., ElBadawy, A., Kaweeteerawat, C., Boren, D., Fischer, H., Ji, Z., Chang, C. H., Liu, R., Tolaymat, T., Telesca, D., et al. (2014) · ACS Nano · doi:10.1021/nn4044047 · Cited by 599
Applerot, G., Lellouche, J., Lipovsky, A., Nitzan, Y., Lubart, R., Gedanken, A., & Banin, E. (2012) · Small · doi:10.1002/smll.201200772 · Cited by 598
Talebian, N., Amininezhad, S. M., & Doudi, M. (2013) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2013.01.004 · Cited by 541
Radovic-Moreno, A. F., Lu, T. K., Puscasu, V. A., Yoon, C. J., Langer, R., & Farokhzad, O. C. (2012) · ACS Nano · doi:10.1021/nn3008383 · Cited by 539
Ramalingam, B., Parandhaman, T., & Das, S. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00161 · Cited by 520
Brunet, L., Lyon, D. Y., Hotze, E. M., Alvarez, P. J. J., & Wiesner, M. R. (2009) · Environmental Science & Technology · doi:10.1021/es803093t · Cited by 469
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms
Forier, K., Raemdonck, K., De Smedt, S. C., Demeester, J., Coenye, T., & Braeckmans, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.055 · Cited by 464
Extracellular polymeric substances, a key element in understanding biofilm phenotype
Di Martino, P., & Groupe Biofilm et Comportement Microbien aux Interfaces, L. E.-E. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.2.274 · Cited by 456
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms
Gebreyohannes, G., Nyerere, A., Bii, C., & Sbhatu, D. B. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02192 · Cited by 414
Infections caused by Gram-positive bacteria: a review of the global challenge
Woodford, N., & Livermore, D. M. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60003-7 · Cited by 410
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Kroll, A. V., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00569 · Cited by 379
Intracellular staphylococcus aureus: Live-in and let die
Fraunholz, M., & Sinha, B. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00043 · Cited by 377
Anti-infective Properties of the Golden Spice Curcumin
Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00912 · Cited by 373
Integrating recognition elements with nanomaterials for bacteria sensing
Chen, J., Andler, S. M., Goddard, J. M., Nugen, S. R., & Rotello, V. M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00313c · Cited by 369
Protein-based nanoparticles: From preparation to encapsulation of active molecules
Tarhini, M., Greige-Gerges, H., & Elaissari, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.067 · Cited by 354
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
Swider, E., Koshkina, O., Tel, J., Cruz, L. J., de Vries, I. J. M., & Srinivas, M. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.006 · Cited by 328
Chitosan Based Self-Assembled Nanoparticles in Drug Delivery
Quiñones, J. P., Peniche, H., & Peniche, C. (2018) · Polymers · doi:10.3390/polym10030235 · Cited by 324
Antimicrobial Activity of Carvacrol: Current Progress and Future Prospectives
Nostro, A., & Papalia, T. (2012) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489112799829684 · Cited by 323
Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224904 · Cited by 307
Du, X., & Qiao, S. Z. (2015) · Small · doi:10.1002/smll.201401201 · Cited by 302
Core–Shell Supramolecular Gelatin Nanoparticles for Adaptive and “On-Demand” Antibiotic Delivery
Li, L.-L., Xu, J.-H., Qi, G.-B., Zhao, X., Yu, F., & Wang, H. (2014) · ACS Nano · doi:10.1021/nn501040h · Cited by 291
Inorganic nanoparticles engineered to attack bacteria
Miller, K. P., Wang, L., Benicewicz, B. C., & Decho, A. W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00041f · Cited by 290
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 267
Fenske, D. B., & Cullis, P. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.25 · Cited by 253
Chitosan and their derivatives: Antibiofilm drugs against pathogenic bacteria
Khan, F., Pham, D. T. N., Oloketuyi, S. F., Manivasagan, P., Oh, J., & Kim, Y.-M. (2020) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2019.110627 · Cited by 246
Biomedical Applications of Gold Nanoparticles
Cabuzu, D., Cirja, A., Puiu, R., & Grumezescu, A. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150414144750 · Cited by 237
Baelo, A., Levato, R., Julián, E., Crespo, A., Astola, J., Gavaldà, J., Engel, E., Mateos-Timoneda, M. A., & Torrents, E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.028 · Cited by 233
Yang, S., Han, X., Yang, Y., Qiao, H., Yu, Z., Liu, Y., Wang, J., & Tang, T. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15678 · Cited by 213
Self-citationSurvival of Helicobacter pylori in gastric acidic territory
Ansari, S., & Yamaoka, Y. (2017) · Helicobacter · doi:10.1111/hel.12386 · Cited by 209
Canaparo, R., Foglietta, F., Giuntini, F., Della Pepa, C., Dosio, F., & Serpe, L. (2019) · Molecules · doi:10.3390/molecules24101991 · Cited by 208
Tamayo, L. A., Zapata, P. A., Vejar, N. D., Azócar, M. I., Gulppi, M. A., Zhou, X., Thompson, G. E., Rabagliati, F. M., & Páez, M. A. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.03.037 · Cited by 207
Pareek, V., Gupta, R., & Panwar, J. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2018.04.093 · Cited by 205
Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA
Poovelikunnel, T., Gethin, G., & Humphreys, H. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv169 · Cited by 192
Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication
Geilich, B. M., Gelfat, I., Sridhar, S., van de Ven, A. L., & Webster, T. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.011 · Cited by 188
Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles
Nguyen, T.-K., Selvanayagam, R., Ho, K. K. K., Chen, R., Kutty, S. K., Rice, S. A., Kumar, N., Barraud, N., Duong, H. T. T., & Boyer, C. (2016) · Chemical Science · doi:10.1039/c5sc02769a · Cited by 187
Price, J. R., Cole, K., Bexley, A., Kostiou, V., Eyre, D. W., Golubchik, T., Wilson, D. J., Crook, D. W., Walker, A. S., Peto, T. E. A., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30413-3 · Cited by 185
Mesoporous Silica‐Based Materials with Bactericidal Properties
Bernardos, A., Piacenza, E., Sancenón, F., Hamidi, M., Maleki, A., Turner, R. J., & Martínez‐Máñez, R. (2019) · Small · doi:10.1002/smll.201900669 · Cited by 181
Casciaro, B., Moros, M., Rivera-Fernández, S., Bellelli, A., de la Fuente, J. M., & Mangoni, M. L. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.09.041 · Cited by 180
Angsantikul, P., Thamphiwatana, S., Zhang, Q., Spiekermann, K., Zhuang, J., Fang, R. H., Gao, W., Obonyo, M., & Zhang, L. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800016 · Cited by 180
Rai, A., Pinto, S., Velho, T. R., Ferreira, A. F., Moita, C., Trivedi, U., Evangelista, M., Comune, M., Rumbaugh, K. P., Simões, P. N., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.051 · Cited by 177
Streptococcus pneumoniae: Invasion and Inflammation
Loughran, A. J., Orihuela, C. J., & Tuomanen, E. I. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0004-2018 · Cited by 175
Subbiahdoss, G., Sharifi, S., Grijpma, D. W., Laurent, S., van der Mei, H. C., Mahmoudi, M., & Busscher, H. J. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.03.002 · Cited by 174
Multifunctionality of gold nanoparticles: Plausible and convincing properties
Ramalingam, V. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.101989 · Cited by 169
Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery
Makowski, M., Silva, Í. C., do Amaral, C. P., Gonçalves, S., & Santos, N. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110588 · Cited by 162
Distribution of Bacteria in the Epidermal Layers and Hair Follicles of the Human Skin
Lange‐Asschenfeldt, B., Marenbach, D., Lang, C., Patzelt, A., Ulrich, M., Maltusch, A., Terhorst‐Molawi, D., Stockfleth, E., Sterry, W., & Lademann, J. M. (2011) · Skin Pharmacology and Physiology · doi:10.1159/000328728 · Cited by 160
Molecular Simulations of Water and Ion Diffusion in Nanosized Mineral Fractures
Kerisit, S., & Liu, C. (2009) · Environmental Science & Technology · doi:10.1021/es8016045 · Cited by 159
Nanoparticles and Surfaces Presenting Antifungal, Antibacterial and Antiviral Properties
Botequim, D., da Maia, J. L., Lino, M. M., Lopes, L. M. F., Simões, P. N., Ilharco, L. M., & Ferreira, L. (2012) · Langmuir · doi:10.1021/la300948n · Cited by 159
Chen, M., Xie, S., Wei, J., Song, X., Ding, Z., & Li, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b16092 · Cited by 158
Antimicrobial Gold Nanoclusters: Recent Developments and Future Perspectives
Yougbaré, S., Chang, T.-K., Tan, S.-H., Kuo, J.-C., Hsu, P.-H., Su, C.-Y., & Kuo, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122924 · Cited by 158
Antibacterial Effects of Chitosan/Cationic Peptide Nanoparticles
Tamara, F. R., Lin, C., Mi, F., & Ho, Y. (2018) · Nanomaterials · doi:10.3390/nano8020088 · Cited by 153
d’Angelo, I., Casciaro, B., Miro, A., Quaglia, F., Mangoni, M. L., & Ungaro, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.027 · Cited by 152
Wallock-Richards, D., Doherty, C. J., Doherty, L., Clarke, D. J., Place, M., Govan, J. R. W., & Campopiano, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112726 · Cited by 151
Insight into the primary mode of action of TiO 2 nanoparticles on Escherichia coli in the dark
Sohm, B., Immel, F., Bauda, P., & Pagnout, C. (2014) · PROTEOMICS · doi:10.1002/pmic.201400101 · Cited by 151
Delivery and Targeting of Nanoparticles Into Hair Follicles
Fang, C.-L., Aljuffali, I. A., Li, Y.-C., & Fang, J. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.61 · Cited by 151
Self-citationCoating nanoparticles with cell membranes for targeted drug delivery
Gao, W., & Zhang, L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1052074 · Cited by 148
The potential anti‐infective applications of metal oxide nanoparticles: A systematic review
Abo‐zeid, Y., & Williams, G. R. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1592 · Cited by 148
Park, H., Park, H.-J., Kim, J. A., Lee, S. H., Kim, J. H., Yoon, J., & Park, T. H. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.10.010 · Cited by 147
Liu, J., Aruguete, D. M., Murayama, M., & Hochella, M. F. (2009) · Environmental Science & Technology · doi:10.1021/es902121r · Cited by 146
Wang, Y., Yuan, Q., Feng, W., Pu, W., Ding, J., Zhang, H., Li, X., Yang, B., Dai, Q., Cheng, L., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0537-4 · Cited by 145
Strategies for New Antimicrobial Proteins and Peptides: Lysozyme and Aprotinin as Model Molecules
Ibrahim, H. R., Aoki, T., & Pellegrini, A. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395349 · Cited by 143
Casciaro, B., d’Angelo, I., Zhang, X., Loffredo, M. R., Conte, G., Cappiello, F., Quaglia, F., Di, Y. P., Ungaro, F., & Mangoni, M. L. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.8b01829 · Cited by 138
Lee, S. E., Stubelius, A., Hamelmann, N. M., Tran, V., & Almutairi, A. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08254 · Cited by 134
Tan, Y., Ma, S., Leonhard, M., Moser, D., Haselmann, G. M., Wang, J., Eder, D., & Schneider‐Stickler, B. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.07.072 · Cited by 133
Nanomedicine as an emerging approach against intracellular pathogens
Li, B., & Armstead (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s27285 · Cited by 131
Dave, V., Yadav, R., Kushwaha, K., Yadav, S., Sharma, S. K., & Agrawal, U. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.07.002 · Cited by 127
Kim, K.-T., Lee, J., Kim, D., Yoon, I., & Cho, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060280 · Cited by 124
Sabale, S. R., Kandesar, P., Jadhav, V., Komorek, R., Motkuri, R. K., & Yu, X. (2017) · Biomaterials Science · doi:10.1039/c7bm00723j · Cited by 122
Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis
Silva, N. C., Baptista-Silva, S., Sarmento, B. F. C. C., & Pintado, M. (2013) · Drug Delivery · doi:10.3109/10717544.2013.858195 · Cited by 117
Hao, N., Li, L., & Tang, F. (2016) · International Materials Reviews · doi:10.1080/09506608.2016.1190118 · Cited by 113
Wang, Y., Nor, Y. A., Song, H., Yang, Y., Xu, C., Yu, M., & Yu, C. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00053c · Cited by 109
Progress on utilizing hyperthermia for mitigating bacterial infections
Ibelli, T. J., Templeton, S. J., & Levi‐Polyachenko, N. H. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1369173 · Cited by 109
Mohammed, Y. H. I., Manukumar, H. M. G., Rakesh, K. P., Karthik, C. S., Mallu, P., & Qin, H. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.07.002 · Cited by 108
Arif, M., Dong, Q., Raja, M. A., Zeenat, S., Chi, Z., & Liu, C. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.08.038 · Cited by 105
Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides
Chen, C., Hu, J., Shengzhong, Z., Zhou, P., Zhao, X., Xu, H., Zhao, X., Yaseen, M., & Lu, J. R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.059 · Cited by 103
Self-citationAn efficient antimicrobial depot for infectious site-targeted chemo-photothermal therapy
Liu, M., He, D., Yang, T., Liu, W., Li, M., Zhu, Y., Wu, J., Luo, G., & Deng, J. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0348-z · Cited by 103
Zhang, S., Sun, X., Chang, W., Dai, Y., & Ma, X. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136082 · Cited by 99
Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles
Tenland, E., Pochert, A., Krishnan, N., Rao, K. U., Kalsum, S., Braun, K., Glegola-Madejska, I., Lerm, M., Robertson, B. D., Lindén, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212858 · Cited by 96
Kalhapure, R. S., Sikwal, D. R., Rambharose, S., Mocktar, C., Singh, S. D., Bester, L. A., Oh, J. K., Renukuntla, J., & Govender, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.010 · Cited by 95
Palange, A. L., Mascolo, D. D., Carallo, C., Gnasso, A., & Decuzzi, P. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.02.004 · Cited by 94
Lewies, A., Wentzel, J. F., Jordaan, A., Bezuidenhout, C. C., & Plessis, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.071 · Cited by 94
Bacteria–nanoparticle interactions and their environmental implications
Aruguete, D. M., & Hochella, M. F. (2010) · Environmental Chemistry · doi:10.1071/en09115 · Cited by 90
Mycobacterium tuberculosis Subverts Innate Immunity to Evade Specific Effectors
Loeuillet, C., Martinon, F., Pérez, C., Muñoz, M., Thome, M., & Meylan, P. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6245 · Cited by 88
Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa
Hadinoto, K., & Cheow, W. S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.032 · Cited by 85
Preparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery
Pradeepa, Vidya, S. M., Mutalik, S., Bhat, K. U., Huilgol, P., & Avadhani, K. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.022 · Cited by 85
Combination drug therapy via nanocarriers against infectious diseases
Walvekar, P., Gannimani, R., & Govender, T. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.017 · Cited by 85
Navani, N. K., Lambadi, P. R., Sharma, T., Kumar, P., Vasnani, P., Thalluri, S. M., Bisht, N., & Pathania, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s72923 · Cited by 84
Basha, R. Y., Sampath Kumar, T. S., & Doble, M. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.04.056 · Cited by 84
Loyer, P., & Cammas‐Marion, S. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.936871 · Cited by 82
Vijayan, V., Uthaman, S., & Park, I. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0445-3_3 · Cited by 82
New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis
Huttunen, R., & Aittoniemi, J. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.08.004 · Cited by 80
How to rewire the host cell: A home improvement guide for intracellular bacteria
Taylor-Cornejo, E., Schlaermann, P., & Mukherjee, S. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201701095 · Cited by 80
Montmorillonite nanodevices for the colon metronidazole delivery
Calabrese, I., Cavallaro, G., Scialabba, C., Licciardi, M., Merli, M., Sciascia, L., & Liveri, M. L. T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.09.017 · Cited by 79
Medina, E., Rohde, M., & Chhatwal, G. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5376-5380.2003 · Cited by 79
Alfatemi, S. H., Rad, M. S., Iriti, M., & Sharifi‐Rad, J. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.144883 · Cited by 79
Zomorodian, K., Veisi, H., Mousavi, M., Ataabadi, M. S., Yazdanpanah, S., Bagheri, M. J., Mehr, A. P., Hemmati, S., & Veisi, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161002 · Cited by 76
Sun, L., Zhang, C.-L., & Li, P. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3010405 · Cited by 74
Alginate Based Nanocarriers for Drug Delivery Applications
Jana, S., Sen, K. K., & Gandhi, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160510125718 · Cited by 74
Chiang, C., Hu, S., Liao, B., Chang, Y., & Chen, S.-Y. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.07.009 · Cited by 71
Mir, M., Ahmed, N., Permana, A. D., Rodgers, A. M., Donnelly, R. F., & Rehman, A. U. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110606 · Cited by 71
Zivich, P. N., Grabenstein, J. D., Becker‐Dreps, S., & Weber, D. J. (2018) · Pneumonia · doi:10.1186/s41479-018-0055-4 · Cited by 70
Poly(β-l-malic acid) (PMLA) from Aureobasidium spp. and its current proceedings
Chi, Z., Liu, C., Liu, C.-G., & Chi, Z. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7404-0 · Cited by 67
Shi, B., Leung, D. Y. M., Taylor, P. A., & Li, H. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.022 · Cited by 67
Shlar, I., Droby, S., Choudhary, R., & Rodov, V. (2017) · RSC Advances · doi:10.1039/c7ra07303h · Cited by 66
Wang, X., Deng, A., Cao, W., Li, Q., Wang, L., Zhou, J., Hu, B., & Xing, X. (2018) · Journal of Materials Science · doi:10.1007/s10853-018-1998-9 · Cited by 66
Alalaiwe, A. S., Wang, P., Lu, P., Chen, Y.-P., Fang, J., & Yang, S.-C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01493 · Cited by 65
Self-citationImproving short antimicrobial peptides despite elusive rules for activity
Mikut, R., Ruden, S., Reischl, M., Breitling, F., Volkmer, R., & Hilpert, K. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.013 · Cited by 64
Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting
Hsu, C., Yang, S.-C., Sung, C. T., Weng, Y.-H., & Fang, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s147226 · Cited by 62
Self-citationSolid lipid nanoparticles for the delivery of anti-microbial oligonucleotides
González-Paredes, A., Sitia, L., Ruyra, À., Morris, C. J., Wheeler, G. N., McArthur, M., & Gasco, P. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.11.017 · Cited by 62
Targeting bacterial biofilms via surface engineering of gold nanoparticles
Giri, K., Yepes, L. R., Duncan, B., Parameswaran, P. K., Yan, B., Jiang, Y. Y., Bílská, M., Moyano, D. F., Thompson, M. A., Rotello, V. M., et al. (2015) · RSC Advances · doi:10.1039/c5ra16305f · Cited by 61
Kumar, G. V., Su, C., & Velusamy, P. (2016) · Materials Letters · doi:10.1016/j.matlet.2016.05.108 · Cited by 61
Magnetic hyperthermia enhance the treatment efficacy of peri-implant osteomyelitis
Fang, C.-H., Tsai, P.-I., Huang, S.-W., Sun, J.-S., Chang, J. Z., Shen, H.-H., Chen, S., Lin, F. H., Hsu, L.-T., & Yen-Chun, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2621-4 · Cited by 61
Javanbakht, T., Laurent, S., Stanicki, D., & Wilkinson, K. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154445 · Cited by 58
Yamakami, K., Tsumori, H., Sakurai, Y., Shimizu, Y., Nagatoshi, K., & Sonomoto, K. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.717227 · Cited by 56
Design of Mannose-Functionalized Curdlan Nanoparticles for Macrophage-Targeted siRNA Delivery
Ganbold, T., & Baigude, H. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b02073 · Cited by 54
Smitha, K. T., Nisha, N., Maya, S., Biswas, R., & Jayakumar, R. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.11.006 · Cited by 52
Cai, S., Qian, J., Yang, S., Kuang, L., & Hua, D. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.05.007 · Cited by 50
Self-citationInsua, I., Liamas, E., Zhang, Z. J., Peacock, A. F. A., Krachler, A. M., & Fernández‐Trillo, F. (2016) · Polymer Chemistry · doi:10.1039/c6py00146g · Cited by 49
Yuan, P., Hu, X.-R., Yao, Q. Z., Hu, Q., Amini, S., Miserez, A., & Tang, G. (2016) · Nanoscale · doi:10.1039/c6nr05551f · Cited by 49
Pu, L., Xu, J., Sun, Y., Fang, Z., Chan‐Park, M. B. E., & Duan, H. (2016) · Biomaterials Science · doi:10.1039/c5bm00545k · Cited by 48
Nanomedical Strategies for Targeting Skin Microbiomes
Aljuffali, I. A., Huang, C., & Fang, J. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150812124923 · Cited by 46
Self-citationMetallic nanoparticles to eradicate bacterial bone infection
Qadri, S., Haik, Y., Mensah‐Brown, E. P. K., Bashir, G. H., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.05.013 · Cited by 43
Fang, J., Lin, Y., Wang, P., Alalaiwe, A. S., Yang, Y., & Yang, S.-C. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s221663 · Cited by 43
Self-citationSynthetic Polymers for Simultaneous Bacterial Sequestration and Quorum Sense Interference
Xue, X., Pasparakis, G., Halliday, N., Winzer, K., Howdle, S. M., Cramphorn, C. J., Cameron, N. R., Gardner, P. M., Davis, B. G., Fernández‐Trillo, F., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201103130 · Cited by 40
HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin
Rani, S., Gothwal, A., Pandey, P. K., Chauhan, D. S., Pachouri, P. K., Gupta, U. D., & Gupta, U. D. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2543-x · Cited by 39
Ribeiro, K. L., Frías, I. A. M., Franco, O. L., Dias, S. C., Sousa-Junior, A. A., Silva, O. N., Bakuzis, A. F., Oliveira, M. D. L., & Andrade, C. A. S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.04.055 · Cited by 38
Jahnke, J. P., Cornejo, J. A., Sumner, J. J., Schuler, A. J., Atanassov, P. B., & Ista, L. K. (2016) · Biointerphases · doi:10.1116/1.4939244 · Cited by 37
Glycosylated Nanoparticles as Efficient Antimicrobial Delivery Agents
Eissa, A. M., Abdulkarim, A., Sharples, G. J., & Cameron, N. R. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00711 · Cited by 36
Wang, X.-S., Situ, J.-Q., Ying, X., Chen, H., Pan, H.-F., Jin, Y., & Du, Y. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.04.010 · Cited by 34
Commentary: One Small Step for the Gram Stain, One Giant Leap for Clinical Microbiology
Thomson, R. B. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00303-16 · Cited by 34
Emerging drugs for cystic fibrosis
Amin, R., & Ratjen, F. A. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.882316 · Cited by 32
Hsu, C., Sung, C. T., Aljuffali, I. A., Chen, C., Hu, K., & Fang, J. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.006 · Cited by 32
Self-citationBajaj, M., Pandey, S. K., Nain, T., Brar, S. K., Singh, P., Singh, S., Wangoo, N., & Sharma, R. K. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.009 · Cited by 31
Lin, M., Hung, C., Aljuffali, I. A., Sung, C. T., Huang, C.-T., & Fang, J. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.011 · Cited by 27
Self-citationKłodzińska, S. N., Priemel, P., Rades, T., & Nielsen, H. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101688 · Cited by 27
Yang, S.-C., Aljuffali, I. A., Sung, C. T., Lin, C., & Fang, J. (2016) · Nanomedicine · doi:10.2217/nnm.15.217 · Cited by 26
Self-citationWen, C.-J., Yen, T., Al‐Suwayeh, S. A., Chang, H., & Fang, J. (2011) · Nanomedicine · doi:10.2217/nnm.11.46 · Cited by 25
Self-citationProtein‐Based Nanoparticles for the Delivery of Enzymes with Antibacterial Activity
Steiert, E., Radi, L., Fach, M., & Wich, P. R. (2018) · Macromolecular Rapid Communications · doi:10.1002/marc.201800186 · Cited by 21
The additional costs of catheter-related bloodstream infections in intensive care units
Nakamura, I., Fukushima, S., Hayakawa, T., Sekiya, K., & Matsumoto, T. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.05.022 · Cited by 17
Yang, S.-C., Yen, F., Wang, P., Aljuffali, I. A., Weng, Y.-H., Tseng, C.-H., & Fang, J. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0044 · Cited by 11
Self-citation
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Hetta, H. F., Ramadan, Y. N., Al-Harbi, A. I., A. Ahmed, E., Battah, B., Abd Ellah, N. H., Zanetti, S., & Donadu, M. G. (2023) · Biomedicines · doi:10.3390/biomedicines11020413 · Cited by 333
Antimicrobial nanoparticles: current landscape and future challenges
Mondal, S. K., Chakraborty, S., Manna, S., & Mandal, S. M. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00032c · Cited by 318
Recent advances in targeted antibacterial therapy basing on nanomaterials
Geng, Z., Cao, Z., & Liu, J. (2023) · Exploration · doi:10.1002/exp.20210117 · Cited by 262
Nanotools for Sepsis Diagnosis and Treatment
Papafilippou, L., Claxton, A., Dark, P., Kostarelos, K., & Hadjidemetriou, M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001378 · Cited by 118
Metadata
- Authors
- Yeh, Y.-C., Huang, T.-H., Yang, S.-C., Chen, C.-C., & Fang, J.-Y.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2020-04-24
- Volume
- 8
- Pages
- 286-286
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W3019923950
- Cited by
- 416
- References
- 166
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.